About this item:

62 Views | 24 Downloads

Author Notes:

Adebola Adedimeji, Email: adebola.adedimeji@einsteinmed.org

AA-conceived and designed the study, obtained funding, supervised data collection and analysis, wrote initial drafts and revised manuscripts. RA-supervised data collection, participated in data analysis, read and approved manuscript. AP-participated in data analysis, contributed to revisions, read and approved manuscript. RN-participated in data analysis, read and approved manuscript. JN-participated in data analysis, read and approved manuscript. NF-read and approved manuscript. DN-contributed to data collection, read and approved manuscript. MN-contributed to analysis, read and approved manuscript. AD-supervised data collection, read and approved manuscript. KMA-conceived and designed study, obtained funding, supervised data collection, read and approved manuscript. PEC-conceived and designed study, obtained funding, supervised data collection, participated in analysis, read and approved manuscript. All authors have read and approved the manuscript.

We want to thank all the women who participated in the study, the management and staff of Limbé Regional Hospital for facilitating the conduct of this study.

The author declare that they have no competing interests. This study received Xpert HPV tests from Cepheid (Sunnyvale, CA, USA) at a reduced cost. Dr. Castle has received HPV tests and assays for research from Roche, Becton Dickinson, Cepheid, and Arbor Vita Corporation at a reduced or no cost.

Subject:

Research Funding:

Research reported in this publication was supported by a supplement (3P30CA013330-43S1A) from the National Cancer Institute to the Albert Einstein Cancer Center (3P30CA013330) and the National Institutes of Health/National Institute of Allergy and Infectious Diseases under Grant Number 5U01AI096299-04 (PI: Anastos and Nash). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.” The funders had no role in conducting the research or reporting the findings.

Keywords:

  • Cervical cancer screening
  • Human immunodeficiency virus (HIV)
  • Cameroon
  • Low-income
  • Social determinants

Challenges and opportunities associated with cervical cancer screening programs in a low income, high HIV prevalence context

Show all authors Show less authors

Tools:

Journal Title:

BMC Womens Health

Volume:

Volume 21

Publisher:

Type of Work:

Article | Final Publisher PDF

Abstract:

Background Cervical cancer is a leading cause of death among Cameroon women. The burden of cervical cancer is in part traceable to the inadequate understanding of socio-contextual determinants of access to screening and prevention opportunities. We explored multilevel individual, community and structural factors that facilitate or inhibit cervical cancer prevention in women at risk in a low-income, high HIV prevalence context. Methods We utilized an exploratory qualitative approach to obtain data through focus group discussions and in-depth interviews from May to August, 2018. A two-stage purposive sampling strategy was used to select 80 women and 20 men who participated in 8 focus group discussions and 8 in-depth interviews. The socio-ecological model guided data analyses to identify micro-, meso-, and macro-level determinants of cervical cancer screening. Results Micro-level factors including lack of awareness and knowledge about cervical cancer, lack of access to information, excessive cost of cervical cancer screening, low risk perceptions, and poor health seeking behaviors were major barriers for women seeking cervical cancer screening. Meso-level factors, such as social networks, socio-cultural norms, perceptions of the role of men and HIV-related stigma when screening is integrated into HIV care, also engender negative attitudes and behaviors. Macro-level barriers to cervical cancer screening included poorly equipped health facilities and a lack of national cancer prevention policies and programs. Conclusion In the context of the call for elimination of cervical cancer as a public health problem, our findings highlight challenges and opportunities that should be considered when implementing interventions to increase uptake of cervical cancer screening in low-middle income settings.

Copyright information:

© The Author(s) 2021

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote